BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23039795)

  • 1. Secreted frizzled-related protein 4 expression is positively associated with responsiveness to cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancers.
    Saran U; Arfuso F; Zeps N; Dharmarajan A
    BMC Cell Biol; 2012 Oct; 13():25. PubMed ID: 23039795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of secreted frizzled-related protein 4 (SFRP4) in primary serous ovarian tumours.
    Drake J; Shearwood AM; White J; Friis R; Zeps N; Charles A; Dharmarajan A
    Eur J Gynaecol Oncol; 2009; 30(2):133-41. PubMed ID: 19480240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients.
    Jacob F; Ukegjini K; Nixdorf S; Ford CE; Olivier J; Caduff R; Scurry JP; Guertler R; Hornung D; Mueller R; Fink DA; Hacker NF; Heinzelmann-Schwarz VA
    PLoS One; 2012; 7(2):e31885. PubMed ID: 22363760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.
    He B; Lee AY; Dadfarmay S; You L; Xu Z; Reguart N; Mazieres J; Mikami I; McCormick F; Jablons DM
    Cancer Res; 2005 Feb; 65(3):743-8. PubMed ID: 15705870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells.
    Carmon KS; Loose DS
    Mol Cancer Res; 2008 Jun; 6(6):1017-28. PubMed ID: 18567805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.
    Deshmukh A; Arfuso F; Newsholme P; Dharmarajan A
    Int J Biochem Cell Biol; 2019 Apr; 109():23-32. PubMed ID: 30710752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells.
    Ford CE; Jary E; Ma SS; Nixdorf S; Heinzelmann-Schwarz VA; Ward RL
    PLoS One; 2013; 8(1):e54362. PubMed ID: 23326605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro.
    Horvath LG; Henshall SM; Kench JG; Saunders DN; Lee CS; Golovsky D; Brenner PC; O'Neill GF; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL
    Clin Cancer Res; 2004 Jan; 10(2):615-25. PubMed ID: 14760084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
    Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
    Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secreted Frizzled-related protein 4 (sFRP4) chemo-sensitizes cancer stem cells derived from human breast, prostate, and ovary tumor cell lines.
    Deshmukh A; Kumar S; Arfuso F; Newsholme P; Dharmarajan A
    Sci Rep; 2017 May; 7(1):2256. PubMed ID: 28536422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
    Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
    Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-181a-SFRP4 Axis Regulates Wnt Activation to Drive Stemness and Platinum Resistance in Ovarian Cancer.
    Belur Nagaraj A; Knarr M; Sekhar S; Connor RS; Joseph P; Kovalenko O; Fleming A; Surti A; Nurmemmedov E; Beltrame L; Marchini S; Kahn M; DiFeo A
    Cancer Res; 2021 Apr; 81(8):2044-2055. PubMed ID: 33574092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of Eag1 Expression by RNA Interference Increases Chemosensitivity to Cisplatin in Ovarian Cancer Cells.
    Hui C; Lan Z; Yue-li L; Li-lin H; Li-lin H
    Reprod Sci; 2015 Dec; 22(12):1618-26. PubMed ID: 26079730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway.
    Su HY; Lai HC; Lin YW; Liu CY; Chen CK; Chou YC; Lin SP; Lin WC; Lee HY; Yu MH
    Int J Cancer; 2010 Aug; 127(3):555-67. PubMed ID: 19957335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
    Yan X; Fraser M; Qiu Q; Tsang BK
    Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E; Mills GB; Tsang BK
    Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells.
    Warrier S; Balu SK; Kumar AP; Millward M; Dharmarajan A
    Oncol Res; 2013; 21(2):93-102. PubMed ID: 24406045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental expression of secreted frizzled related protein-4 in the rat and the impact of glucocorticoid-induced fetal and placental growth restriction.
    Hewitt DP; Mark PJ; Dharmarajan AM; Waddell BJ
    Biol Reprod; 2006 Jul; 75(1):75-81. PubMed ID: 16540541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.